As a leading radiopharmaceutical manufacturer in Australia and New Zealand, our mission at Cyclotek is to improve patient outcomes with accessible targeted radiopharmaceuticals. Our novel PET-tracers provide patient-specific insights into their disease state, providing earlier diagnosis, more accurate assessment of disease extent and improved treatment planning and motoring. Cyclotek offers a range of radiopharmaceutical products in oncology and neurology, bringing patient-centred diagnostics to life. With the unlocking of the human genome and ever more sophisticated chemistry innovation, we seek to advance therapeutic discovery, further refine diagnostic pathways and drive higher standards in personalised medicine.

Website: cyclotek.com

Employees: 100 - 249

HQ: N/A

Location: Australia & New Zealand, N/A, au

Revenue: 2.5 - 5 Million

Are you looking for contact information for Cyclotek Pty Ltd? Look no further than ConnectPlex.ai! Our comprehensive database contains company information for millions of companies around the world, including Cyclotek Pty Ltd. Our AI-powered algorithms ensure that our data is up-to-date and accurate, so you can be sure that you're getting the most reliable contact information available. Whether you're looking to connect with key decision-makers or simply need to get in touch with someone at Cyclotek Pty Ltd, ConnectPlex.ai is the right place to start your search. At ConnectPlex.ai, we understand the importance of accurate and up-to-date contact information. That's why we've developed a sophisticated system that constantly updates and verifies our data to ensure that it's always current and reliable. Our user-friendly interface makes it easy to search for and connect with people at Cyclotek Pty Ltd, so you can start building valuable business relationships in no time. Try ConnectPlex.ai today and see the difference that accurate contact information can make for your business!

Cyclotek Pty Ltd is a leading radiopharmaceutical manufacturer in Australia and New Zealand, dedicated to improving patient outcomes through accessible targeted radiopharmaceuticals. With a focus on patient-centred diagnostics, Cyclotek offers a range of radiopharmaceutical products in oncology and neurology, providing earlier diagnosis, more accurate assessment of disease extent, and improved treatment planning and monitoring. The company's mission is to advance therapeutic discovery and drive higher standards in personalised medicine, leveraging the unlocking of the human genome and cutting-edge chemistry innovation. Cyclotek's novel PET-tracers provide patient-specific insights into disease states, enabling more effective treatment strategies and better patient outcomes. With a strong commitment to innovation and patient care, Cyclotek has established itself as a trusted name in the radiopharmaceutical industry. The company's dedication to improving patient outcomes has earned it a reputation as a leader in the field, and its products have had a positive impact on the lives of countless patients.

Cyclotek is a company that makes medical drugs used in imaging tests. They want to help patients by making sure doctors have the best tools to diagnose and treat diseases. They make different drugs for cancer and brain diseases. They also want to use new science and technology to make treatments that are tailored to each patient's needs.